Blincyto (blinatumomab) - Astellas, Amgen
Besponsa (inotuzumab ozogamicin) - Pfizer, UCB
cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
CD22-CAR T-cell therapy - Stanford University, Adaptive Biotech
https://ash.confex.com/ash/2022/webprogram/Paper164456.html
 
Nikeshan Jeyakumar, MD1, Sneha Ramakrishna, MD2, Matthew J Frank, MD, PhD3, Bita Sahaf, PhD4*, Steven A. Feldman, PhD4*, David B. Miklos, MD, PhD5, Crystal L. Mackall, MD6, Kara L. Davis, D.O.7, Lori Muffly, MD, MS8 and Liora M. Schultz, MD9
 
Nov 4, 2022
 
Prev Next